HomeHRTX • NASDAQ
Heron Therapeutics Inc
add
$1.87
0.53%
After Hours:(2.67%)+0.050
$1.92
Closed: May 22, 4:11:37 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 38.90M | 12.21% |
Operating expense | 25.01M | -5.31% |
Net income | 2.64M | 183.39% |
Net profit margin | 6.77 | 174.31% |
Earnings per share | 0.01 | 150.00% |
EBITDA | 3.71M | 190.17% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 50.68M | -29.14% |
Total assets | 235.75M | 8.20% |
Total liabilities | 264.21M | 4.99% |
Total equity | -28.45M | — |
Shares outstanding | 152.56M | — |
Price to book | -9.89 | — |
Return on assets | 3.36% | — |
Return on capital | 5.38% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 2.64M | 183.39% |
Cash from operations | -8.87M | 6.79% |
Cash from investing | 2.27M | 77.86% |
Cash from financing | 64.00K | 481.82% |
Net change in cash | -6.53M | 20.59% |
Free cash flow | -10.39M | -2.68% |
Previous close
$1.88
Day range
$1.85 - $1.91
Year range
$1.04 - $3.93
Market cap
285.29M USD
Avg Volume
1.81M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1983
Headquarters
Website
Employees
122
